180 related articles for article (PubMed ID: 34423573)
1. Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum.
Terävä J; Verhassel A; Botti O; Islam MK; Leivo J; Wittfooth S; Härkönen P; Pettersson K; Gidwani K
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1540. PubMed ID: 34423573
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
3. Probing Aberrantly Glycosylated Mucin 1 in Breast Cancer Extracellular Vesicles.
Saroj S; Paul D; Ali A; Andreou C; Pal S; Rakshit T
ACS Appl Bio Mater; 2023 Nov; 6(11):4944-4951. PubMed ID: 37824707
[TBL] [Abstract][Full Text] [Related]
4. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
[TBL] [Abstract][Full Text] [Related]
5. Mucin glycoproteins as tumor markers.
Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
[TBL] [Abstract][Full Text] [Related]
6. Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera.
Choi JW; Moon BI; Lee JW; Kim HJ; Jin Y; Kim HJ
Oncol Rep; 2018 Jul; 40(1):145-154. PubMed ID: 29749490
[TBL] [Abstract][Full Text] [Related]
7. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
8. Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).
Hanson RL; Hollingsworth MA
Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27483328
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Aided Detection of Colorectal Cancer-Associated Glycoconjugates of Extracellular Vesicles in Human Serum.
Vinod R; Mahran R; Routila E; Leivo J; Pettersson K; Gidwani K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638669
[TBL] [Abstract][Full Text] [Related]
10. Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
Terävä J; Tiainen L; Lamminmäki U; Kellokumpu-Lehtinen PL; Pettersson K; Gidwani K
PLoS One; 2019; 14(7):e0219480. PubMed ID: 31344060
[TBL] [Abstract][Full Text] [Related]
11. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation.
Cao Y; Blohm D; Ghadimi BM; Stosiek P; Xing PX; Karsten U
J Histochem Cytochem; 1997 Nov; 45(11):1547-57. PubMed ID: 9358856
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients.
Linsley PS; Brown JP; Magnani JL; Horn D
Cancer Res; 1988 Apr; 48(8):2138-48. PubMed ID: 2450646
[TBL] [Abstract][Full Text] [Related]
13. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
[TBL] [Abstract][Full Text] [Related]
14. Measuring the multifaceted roles of mucin-domain glycoproteins in cancer.
Riley NM; Wen RM; Bertozzi CR; Brooks JD; Pitteri SJ
Adv Cancer Res; 2023; 157():83-121. PubMed ID: 36725114
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic ability of different human milk fat globule antigens in breast cancer.
Ceriani RL; Blank EW; Rosenbaum EH; Ben Zeev D; Lowitz RS; Johansen L; Trujillo T
Breast Cancer Res Treat; 1990 May; 15(3):161-74. PubMed ID: 2372570
[TBL] [Abstract][Full Text] [Related]
16. Epitope expression on the breast epithelial mucin.
Ceriani RL; Peterson JA; Blank EW; Lamport DT
Breast Cancer Res Treat; 1992; 24(2):103-13. PubMed ID: 7680246
[TBL] [Abstract][Full Text] [Related]
17. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK
Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215
[TBL] [Abstract][Full Text] [Related]
18. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
19. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
